Gopalakrishnan Venkatesan | Medicinal Chemistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr Gopalakrishnan Venkatesan | Medicinal Chemistry | Best Researcher Award

Dr Gopalakrishnan Venkatesan , National University of Singapore  , Singapore

Gopalakrishnan Venkatesan is a distinguished Senior Research Fellow at the National University of Singapore’s Department of Pharmacy. With a Ph.D. in Medicinal Chemistry from NUS, his expertise spans synthetic organic chemistry, medicinal chemistry, and drug metabolism. Dr. Venkatesan has made significant contributions to research with 30 peer-reviewed publications and 3 US patents, including groundbreaking work on adenosine receptor antagonists and alternative hair dyes. His innovative research has been featured in prominent media such as NUS Alumnus and Zaobao Magazine. Renowned for his proficiency in various analytical techniques and biological assays, he has consistently delivered high-impact results in both academic and industry settings.

Publication Profile

Google Scholar

Strengths for the Award

  1. Extensive Research Experience:
    • Gopalakrishnan Venkatesan has a robust background in research with positions at prestigious institutions, including the National University of Singapore and MIT’s SMART. His roles span various research areas, demonstrating versatility and depth in his field.
  2. Publication Record:
    • He has published 30 research papers in international peer-reviewed journals, covering a broad range of topics in chemistry and pharmacology. This indicates a high level of scholarly productivity and impact.
  3. Patent Contributions:
    • Venkatesan has been involved in filing 3 US patents, showcasing his contributions to practical and innovative solutions in his field.
  4. Expertise in Multiple Areas:
    • His expertise spans synthetic organic chemistry, medicinal chemistry, drug metabolism, biological assays, and computational chemistry. This multidisciplinary skill set enhances his ability to tackle complex research problems.
  5. Industry and Academic Experience:
    • His experience includes both academic research and industry roles, such as his time at Ranbaxy Laboratories Ltd, which enriches his understanding of both theoretical and applied aspects of research.
  6. Awards and Recognition:
    • He has received recognition for his work, including the Best Poster Presentation Award at an international symposium, reflecting his ability to effectively communicate his research.
  7. Invention and Media Coverage:
    • His drug patent invention has received media coverage, highlighting the real-world impact of his research.

Areas for Improvement

  1. Broader Impact and Outreach:
    • While Venkatesan has made significant contributions, increasing his engagement in broader scientific communities through more public talks or collaborative interdisciplinary projects could further amplify his impact.
  2. Leadership and Mentoring:
    • The resume focuses heavily on his research output and technical skills. Demonstrating leadership in guiding junior researchers or contributing to institutional development could strengthen his candidacy for awards that consider leadership qualities.
  3. Diverse Research Focus:
    • While he has expertise in several areas, showing evidence of how his research has addressed a diverse range of scientific and societal problems could make his application stand out more.

 

Education 

Gopalakrishnan Venkatesan holds a Ph.D. in Medicinal Chemistry from the National University of Singapore (NUS), completed in April 2014 under the supervision of Prof. Giorgia Pastorin. His doctoral research focused on the design, synthesis, and molecular modeling of pyrazolo(3,4-d)pyrimidine analogues as adenosine receptor antagonists. Prior to this, he earned an M.Pharm in Pharmaceutical and Medicinal Chemistry from the Birla Institute of Technology (BIT), Mesra, India, where he graduated with First Class honors in July 2008. His academic journey began with a B.Pharm from The Tamilnadu Dr M.G.R Medical University, Chennai, India, graduating with First Class in September 2004. These academic achievements laid a strong foundation for his extensive research career in medicinal chemistry and pharmacokinetics.

Experience

Dr. Gopalakrishnan Venkatesan has an extensive research career, currently serving as a Senior Research Fellow at NUS’s Department of Pharmacy since March 2023. He previously worked as a Senior Postdoctoral Research Associate at the Singapore-MIT Alliance for Research and Technology (SMART) from April 2021 to December 2022, leading studies on RNA modifications. His earlier roles include research fellowships at NUS’s Department of Pharmacy from June 2014 to March 2021 and a research associate position from January to April 2014. Dr. Venkatesan’s industry experience includes his tenure as a Research Associate at Ranbaxy Laboratories Ltd, focusing on clinical pharmacology and pharmacokinetics. His work involves expertise in LC-MS/MS assays, organic synthesis, and biological assays, showcasing a robust blend of academic and practical experience in the field.

Awards and Honors 

Dr. Gopalakrishnan Venkatesan has been recognized for his outstanding contributions to research. He received the NUS Research Scholarship for his Ph.D. studies from August 2009 to August 2013. In June 2012, he was awarded the Best Poster Presentation at the AAPS-NUS 7th PharmSci@Asia Symposium, Singapore, highlighting his excellence in presenting complex research findings. These accolades reflect his commitment to advancing scientific knowledge and his ability to communicate his research effectively. His achievements underscore his dedication to innovation and excellence in the field of medicinal chemistry.

Research Focus 

Dr. Gopalakrishnan Venkatesan’s research focuses on synthetic organic chemistry, medicinal chemistry, and drug metabolism. His work emphasizes the design and development of novel therapeutic agents, particularly adenosine receptor antagonists, and alternative hair dyes. He has made significant contributions to understanding RNA modifications and their role in disease, using advanced techniques such as LC-MS/MS. Dr. Venkatesan’s research extends to drug metabolism and pharmacokinetics, where he applies his expertise to improve drug efficacy and safety. His innovative approaches and comprehensive analyses are aimed at developing new therapies and enhancing existing ones, driving progress in the field of pharmaceutical sciences.

Publications Top Notes

“Plasma metabonomic profiling of diabetic retinopathy” 🩸📉

“The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches” 🧬🔬

“Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites” 💊🔬

“Application of static modeling in the prediction of in vivo drug–drug interactions between rivaroxaban and antiarrhythmic agents based on in vitro inhibition studies” 💡💉

“Inactivation of human cytochrome P450 3A4 and 3A5 by dronedarone and N-desbutyl dronedarone” 🧪⚗️

“Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson’s disease treatment” 🧩🧠

“Development of novel alternative hair dyes to hazardous para-phenylenediamine” 💇‍♀️🌿

“Organoruthenium Antagonists of Human A3 Adenosine Receptors” ⚙️🔬

“Site-directed deuteration of dronedarone preserves cytochrome P4502J2 activity and mitigates its cardiac adverse effects in canine arrhythmic hearts” ❤️🔬

“Discovery of simplified N2-substituted pyrazolo [3, 4-d] pyrimidine derivatives as novel adenosine receptor antagonists: Efficient synthetic approaches, biological evaluations” 🔍🧪

“Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists” 🔬🧬

“Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure‐Activity Relationships” 🔬🧪

“Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound healing” 🧫✨

“Lyophilization preserves the intrinsic cardioprotective activity of bioinspired cell-derived nanovesicles” 🧪💖

“Facile synthesis of oligo anilines as permanent hair dyes: how chemical modifications impart colour and avoid toxicity” 🎨🧪

“Bitter Gourd (Momordica charanta) peroxidase in decolorization of dyes from tannery effluent” 🍃💧

“Heteroleptic ruthenium (II) complexes with bathophenanthroline and bathophenanthroline disulfonate disodium salt as fluorescent dyes for in-gel protein staining” 💎🔬

“A facile and novel synthesis of N2-, C6-substituted pyrazolo [3, 4-d] pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists” 🧪🔍

“Synthesis and assessment of non-allergenic aromatic amine hair dyes as efficient alternatives to paraphenylenediamine” 🧑‍🔬🌿

“An exploratory analysis of effects of poyendarone, a deuterated analogue of dronedarone, on the canine model of paroxysmal atrial fibrillation” 🐕❤️

Conclusion

Gopalakrishnan Venkatesan appears to be a strong candidate for the “Best Researcher Award” due to his extensive research experience, significant publication and patent record, and broad expertise. His work has already made a notable impact in his field, as evidenced by his publications, patents, and media coverage. To further bolster his candidacy, he could emphasize his contributions to leadership and mentorship roles, as well as expand on how his research addresses a wide array of scientific and societal issues. Overall, his achievements and contributions suggest that he is well-suited for recognition as a leading researcher in his field.

Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Ms. Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Associate Professor, S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, India

Dr. Baby Rabiya Parveen is a dedicated researcher currently pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. With a Master’s in Pharmaceutical Chemistry and a Bachelor’s in Pharmacy, both from S.D. College of Pharmacy, her academic journey has been marked by excellence and a commitment to advancing pharmaceutical sciences. Her research interests span the synthesis of novel pharmaceutical compounds and their biological evaluations, contributing significantly to her field. 🌟

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Educational Background: Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry and holds both a Master’s and Bachelor’s degree in Pharmaceutical Chemistry with impressive academic performance.
  2. Diverse Workshop Participation: She has actively participated in numerous workshops and faculty development programs covering a wide range of topics relevant to pharmaceutical research, including intellectual property rights, drug regulatory affairs, and biotechnological applications.
  3. Research Contributions: Rabiya has contributed significantly to the field with multiple research papers on topics such as novel oxazine derivatives, antimicrobial agents, and drug synthesis. Her work on molecular docking and synthesis of new compounds demonstrates a strong commitment to advancing pharmaceutical science.
  4. Conference Presentations: She has presented her research at several national and international conferences, showcasing her work to a broader scientific audience and contributing to the dissemination of knowledge in the field.
  5. Industrial Experience: Her industrial training at Deepali Pharmaceuticals adds practical experience to her academic achievements, enhancing her understanding of real-world applications of her research.
  6. Book Chapters: Rabiya has contributed chapters to books on advanced topics like metallic nanoparticles and ghee standards, reflecting her expertise and ability to communicate complex concepts.

Areas for Improvement:

  1. Publication Record: While Rabiya has a commendable list of research papers, increasing the number of high-impact publications in top-tier journals could further strengthen her research profile.
  2. Research Impact: Demonstrating the practical impact of her research on pharmaceutical practice or policy could provide more evidence of her work’s significance.
  3. Collaborative Research: Engaging in collaborative projects with researchers from other institutions or industries might enhance the scope and applicability of her research.
  4. Grants and Funding: Securing research grants and funding could support more extensive studies and increase her visibility in the research community.

Education

Dr. Baby Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. She completed her Master of Pharmacy in Pharmaceutical Chemistry with honors from S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, and her Bachelor of Pharmacy from the same institution. Her academic background also includes a high distinction in both Intermediate and High School studies. 📚

Experience

Dr. Parveen has gained practical experience through a 45-day industrial training at Deepali Pharmaceuticals, Muzaffarnagar, where she applied her theoretical knowledge to real-world pharmaceutical practices. This hands-on experience complements her extensive academic training and research work. 🏭

Research Focus

Dr. Parveen’s research primarily focuses on the synthesis of novel pharmaceutical compounds and their pharmacological activities. Her work includes the development of new oxazine derivatives, Schiff bases, and isoxazole compounds, with a keen interest in their anti-inflammatory, antimicrobial, and anxiolytic activities. Her research contributes to the development of new therapeutic agents. 🔬

Awards and Honours

Dr. Parveen has been recognized for her academic and research achievements through various awards and honors. Her contributions to pharmaceutical sciences have been acknowledged in multiple conferences and workshops, reflecting her commitment to advancing the field. 🏆

Publications

“Synthesis of some new 3-[5-(substituted-phenyl)-[1,3,4]oxadiazole-2-yl]-1-napthalen-2-yl-propan-1-one” – Published in [Journal Name, Year].

“Synthesis and Biological Evaluation of Some New Amide Derivatives of Sulfonamide” – Published in [Journal Name, Year].

“Synthesis and biological evaluation of some new Schiff base 1,2,4-Triazole Derivatives” – Published in [Journal Name, Year].

“A Short Review on Sulfonamides with Antimicrobial Activity” – Published in [Journal Name, Year].

“A Short Review on Synthesis and Pharmacological Activity of Isoxazole” – Published in [Journal Name, Year].

Conclusion:

Baby Rabiya Parveen is a strong candidate for the Research for Best Researcher Award due to her solid educational background, active participation in professional development, significant research contributions, and industrial experience. Her diverse expertise and dedication to advancing pharmaceutical sciences are commendable. Addressing the areas for improvement, particularly in increasing high-impact publications and demonstrating the practical impact of her research, could further solidify her position as a leading researcher in her field.

 

Vuanghao Lim | Pharmaceutical Science | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Assoc Prof Dr. Vuanghao Lim | Pharmaceutical Science | Best Researcher Award

University Lecturer, USM, Malaysia

👨‍🔬 Lim Vuanghao is an Associate Professor at the Advanced Medical and Dental Institute, Universiti Sains Malaysia (USM). His extensive work in nanodrug delivery and green nano-synthesis has made him a recognized figure in the fields of pharmaceutical technology and metabolomics. He has held various leadership roles, including Head of the Integrative Medicine Cluster at USM. Lim’s research focuses on cutting-edge therapeutic strategies, emphasizing targeted drug delivery and the application of metabolomics in medical sciences.

Profile

Google Scholar

Strengths for the Award

Extensive Research Experience: Dr. Lim Vuanghao has a rich background in nanodrug delivery, green nano-synthesis, and metabolomics/chemometrics. His research contributions are well-documented across multiple platforms, including Web of Science, ORCID, Scopus, and Google Scholar.

Diverse Educational Background: Dr. Lim’s academic qualifications are impressive, with a Ph.D. in Pharmaceutical Technology, an M.Sc. in Pharmacy, a B.Sc. in Chemical Sciences, and additional qualifications in Acupuncture and Energy Medicine. This multidisciplinary education underpins his innovative research in nanotechnology and drug delivery systems.

Successful Grant Acquisition: Dr. Lim has secured significant research funding both internationally and nationally, demonstrating his capability to attract and manage research projects. These grants, such as those for breast cancer research and nanocomposite drug delivery systems, highlight his focus on high-impact research areas.

Graduate Supervision and Mentorship: He has successfully supervised several Ph.D. and Master’s students, which speaks to his role in developing the next generation of researchers. His supervision has led to the completion of innovative theses on topics such as green synthesis of nanoparticles and drug delivery systems.

Professional Recognition and Impact: Dr. Lim has been invited as a keynote speaker and research consultant on numerous occasions, indicating his expertise is well-recognized globally. His visiting fellowships and academic appointments in various countries further emphasize his international standing.

Professional and Community Service: His involvement in professional associations, such as the American Chemical Society and the Malaysian Institute of Chemistry, and his community service, particularly in environmental education and herbal medicine exploration, demonstrate a commitment to applying his expertise beyond academia.

Areas for Improvement

Publication Impact: While Dr. Lim’s research is broad and multidisciplinary, a focus on increasing the impact factor of his publications could strengthen his candidacy. Targeting top-tier journals and increasing citation metrics might further solidify his reputation as a leading researcher.

Research Diversity: Although Dr. Lim has a strong focus on nanotechnology and drug delivery, expanding his research into newer or emerging areas within pharmaceutical sciences could broaden his influence. Engaging in collaborative projects across different disciplines might also bring new perspectives and innovation.

Industry Collaboration: While Dr. Lim has some experience in consulting and contract research, increasing partnerships with the industry could enhance the practical application of his research. Establishing stronger ties with pharmaceutical companies or biotech firms could lead to commercialization opportunities.

Global Presence: Despite his international fellowships and visiting positions, further enhancing his global presence by leading international research consortia or hosting global conferences could elevate his profile further. Participation in global initiatives and publishing in international collaborations could be beneficial.

Education

🎓 Lim Vuanghao holds a PhD in Pharmaceutical Technology (2010) and an MSc in Pharmacy (2005) from Universiti Sains Malaysia. He also earned a B.Sc. (Hons) in Chemical Sciences from Universiti Putra Malaysia in 2002. Further enhancing his medical expertise, Lim completed a Doctor of Medicine in Acupuncture from the Indian Board of Alternative Medicines and a Diploma in Clinical Acupuncture and Energy Medicine from Xiamen University, China.

Experience

👨‍🏫 Lim Vuanghao has an extensive academic career, starting as a Research Assistant at the School of Pharmaceutical Sciences, USM, and later as a Lecturer at UCSI University. He has also served as the Head of the Integrative Medicine Cluster at USM, where he played a crucial role in advancing the institute’s research capabilities. Lim is also an active member of various grant evaluation panels and research committees.

Research Interest

🔬 Lim Vuanghao’s research interests revolve around nanodrug delivery systems, green nano-synthesis, and the application of metabolomics and chemometrics in medical research. His work aims to develop innovative therapeutic strategies, including targeted drug delivery systems for cancer treatment and the use of metabolomics to understand disease mechanisms better.

Awards

🏆 Lim Vuanghao has received numerous accolades, including an Academic Fellow Scheme (2023) at Universitas Airlangga, Indonesia, and a Senior Visiting Fellowship at Khesar Gyalpo University of Medical Sciences, Bhutan. His contributions to research have also been recognized through Visiting Professorships and Research Scholarships at various international institutions.

Publications Top Notes

📝 Selected Publications:

“Development of Quercetin PEGylated Nanodiamonds for Colon Cancer Inhibition” (2021, Universitas Airlangga). Link to Publication – Cited by 10 articles.

“Medicinal Herb of Clinacanthus Nutans for Nasopharyngeal Cancer: Biological Activity and Mechanism” (2021, Xinxiang Medical University). Link to Publication – Cited by 15 articles.

“Thiolated Alginate-PLGA Nanoparticles for Multi-Drug Resistant Breast Cancer” (2019, USM). Link to Publication – Cited by 20 articles.

Conclusion

Dr. Lim Vuanghao is a strong candidate for the “Best Researcher Award” due to his extensive research contributions, successful mentorship, and professional recognition. His work in nanodrug delivery and metabolomics is highly impactful, and his dedication to both academia and community service underscores his holistic approach to science. While there is room for growth in publication impact, research diversity, and industry collaboration, his current achievements position him as a leading figure in his field. His recognition as a global expert and his ability to secure substantial research funding further support his candidacy for this prestigious award.

Yan Ni | Pharmaceutical Research | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Yan Ni | Pharmaceutical Research | Best Researcher Award

Executive Director, Passage bio, United States

Profile

Google Scholar

Researcher Evaluation for “Best Researcher Award”

Strengths for the Award:

Extensive Expertise in Drug Development: Yan G. Ni, PhD, has over 15 years of experience in drug development, particularly in small molecules, biologics, and gene therapies. His work spans several critical therapeutic areas, including neurological and cardiovascular diseases, immune-oncology, hematology, and rare diseases. His contributions to IND/CTA submissions and regulatory interactions further highlight his deep involvement in the field.

Leadership in Translational Biomarker and Precision Medicine: Dr. Ni has demonstrated significant expertise in integrating preclinical and clinical biomarker strategies, contributing to the successful design and execution of biomarker-based clinical endpoints. His role in implementing PK and immunogenicity strategies across different phases of studies showcases his ability to bridge the gap between research and clinical application, a crucial factor in modern drug development.

Proven Management Skills: Dr. Ni’s management experience is evident in his ability to build and lead high-performing cross-functional teams. His leadership roles in international professional organizations like the AAPS and SAPA, as well as his track record of mentoring and inspiring others, underline his effectiveness as a leader in both scientific and organizational contexts.

High Scientific Productivity: With over 35 peer-reviewed publications, several book chapters, and six U.S. patents, Dr. Ni’s scientific output is substantial. His contributions to industry white papers and his role as an organizer and invited speaker at national and international conferences further affirm his thought leadership in the field.

Recognition and Awards: Dr. Ni has received numerous prestigious awards, such as the Passage Bio High Impact Award, Regeneron High Impact Award, AAPS Excellence in Ligand Binding Assays Award, and Merck Award of Excellence. These accolades reflect his high-impact contributions to the field and recognition by peers and industry leaders.

Areas for Improvement:

Broader Impact Beyond Specialized Fields: While Dr. Ni’s expertise is well-recognized within specialized areas such as biomarkers, precision medicine, and drug development, expanding his influence into broader, interdisciplinary research domains could enhance his candidacy for a “Best Researcher Award.” For example, engaging in research that impacts public health or other critical global issues might increase his visibility and impact.

Further Innovation in Emerging Therapeutic Areas: While Dr. Ni has made significant contributions to established therapeutic areas, greater involvement in cutting-edge fields such as artificial intelligence in drug discovery or personalized medicine could position him as a pioneer in these rapidly evolving areas.

Enhanced Collaboration with Global Initiatives: Although Dr. Ni has demonstrated leadership in professional organizations and consortia, expanding his collaborative efforts to include global health initiatives or large-scale, multi-national research projects could further amplify his contributions and align with broader global research priorities.

Professional Experience

Passage Bio, Philadelphia, PA
Executive Director, Biomarkers and Precision Medicine
2021-Present
Senior Director, Head of Biomarkers and Precision Medicine
2020-2021

Built and led a high-performing team responsible for driving clinical biomarker, PK/biodistribution, immunogenicity studies, and supporting clinical operations.

Developed and implemented biomarker, PK, and immunogenicity strategies to inform decision-making for neurodegenerative disease portfolios.

Led biomarker and precision medicine support for IND/CTA submissions and global regulatory interactions.

Oversaw partnerships with external CROs and laboratories, and collaborated with Clinical Study Teams on biomarker inclusion in clinical portfolios.

Regeneron, Tarrytown, NY
Associate Director, Precision Medicine, Early Clinical Development & Experimental Sciences
2016-2020

Designed and implemented biomarker strategies to support dose selection and efficacy readings for complement-mediated rare diseases.

Provided strategic leadership for discovery and early cardiovascular programs, influencing biomarker-driven decisions on target validation, disease indication selection, and patient stratification.

Led multiple biomarker-focused natural history studies with academic and clinical centers.

Bristol Myers Squibb, Princeton, NJ
Senior Research Investigator II, R&D/PD/ABD/BAS-Biologics
2012-2016

Supported biomarker bioanalytical strategy implementation for immuno-oncology, immunology, and cardiovascular diseases.

Supervised biomarker method development and validation by internal staff and CROs.

Provided strategic and technical input on biomarker bioanalytical plans, resources, and timelines for FIH and PoC studies.

Merck & Co., Inc., Rahway, NJ
Senior Research Scientist, Cardiovascular Franchise Atherosclerosis Group
2007-2011

Led the development of a 2nd generation fully human monoclonal antibody for PCSK9.

Established ELISA-based pharmacodynamics and target engagement biomarker assays.

University of Texas Southwestern Medical Center, Dallas, TX
Research Assistant Professor, Internal Medicine Department, Cardiology
2001-2007
Research Scientist, Department of Pharmacology & Alliance for Cellular Signaling
2001-2007

Conducted research on cardiac hypertrophy, heart failure, and aging, focusing on Akt and FOXO transcriptional factors.

Education and Training

Persuasive Leadership Development: Wharton Business School, University of Pennsylvania

Postdoctoral Training: Yale University, under Professors Gary Rudnick and Eric Nestler

Ph.D. in Neuroscience: University of California, Irvine, under Professor Ricardo Miledi

M.S. in Pharmacology: Institute of Basic Medical Sciences, Beijing, China

B.S. in Biochemistry: Anhui University, Hefei, China

Professional Honors

Passage Bio High Impact Award (2021)

Regeneron High Impact Award and Multiple STAR Awards (2016-2020)

AAPS Excellence in Ligand Binding Assays Award (2015)

BMS R&D ROC Award and Multiple STAR Awards (2014)

Merck Award of Excellence (2007, 2008, 2009)

Professional Affiliations

American Association of Pharmaceutical Scientists (AAPS):

Founding Member and Chair of the Biomarkers and Translational Medicine Community

Founding Member and Chair of the Gene and Cell Therapeutic Products Community

Sino-American Pharmaceutical Professionals Association (SAPA):

Director for Public Outreach and Executive Committee Member

Publications

Yang, J., Mapelli, C., Wang, Z., et al. (2022). An Optimized Agonist Peptide of Protease-activated Receptor 4 and its Use in a Platelet Aggregation Assay to Monitor the Pharmacodynamic Effects of PAR4 Antagonists. Platelets. DOI: 10.1080/09537104.2022.2053091

Hays, A., Amaravadi, L., Fernandez-Metzler, C., et al. (2022). Is Incurred Sample Reanalysis (ISR) applicable in Biomarker Assays? AAPS J, 24:65. DOI: 10.1208/s12248-022-00708-y

Ni, Y.G., King, L., Fernández-Metzler, C. (2022). Recent Progress in Biomarker Bioanalysis and Target Engagement in Bioanalytical Aspects in Biological Therapeutics. ISBN: 9781119523215. Edited by Xu, X. & Xu, W.

Conclusion:

Dr. Yan G. Ni, PhD, is an outstanding candidate for the “Best Researcher Award” based on his extensive contributions to drug development, biomarker research, and precision medicine. His leadership, scientific productivity, and recognition by peers make him a strong contender for the award. However, expanding his research impact into broader and more emerging fields could further strengthen his profile for this prestigious recognition.